mass spectrometry-based mutation profiling assay (Sequenom)
Structured Review
Mass Spectrometry Based Mutation Profiling Assay, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mutation+profiling/mass+spectrometry+array+mutation+profiling+massarray+system/pmc05691362-110-15-20
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Erlotinib versus Radiation Therapy for Brain Metastases in Patients with EGFR -Mutant Lung Adenocarcinoma Article Snippet: Beginning in January 2009, 92 specific point mutations in multiple genes were identified using a Article Title: Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers Article Snippet: Beginning in January 2009, a mass spectrometry–based mutation profiling assay (Sequenom) was used on all samples. Article Title: Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry. Article Snippet: 0002-9610/$ see front matter 2013 http://dx.doi.org/10.1016/j.amjsurg.20 Abstract BACKGROUND: Determining the molecular profile of colon and rectal cancers offers the possibility of personalized cancer treatment.. The purpose of this study was to determine whether known genetic mutations associated with colorectal carcinogenesis differ between colon and rectal cancers and whether they are associated with survival.. METHODS: The Oregon Colorectal Cancer Registry is a prospectively maintained, institutional review board–approved tissue repository with associated demographic and clinical information. Article Title: Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers Article Snippet: Beginning in January 2009, a Article Title: Patterns of Initial and Intracranial Failure in Metastatic EGFR-mutant Non-Small Cell Lung Cancer Treated with Erlotinib Article Snippet: Beginning in January 2009, 92 specific point mutations in multiple genes were identified by use of a Article Title: Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas Article Snippet: Determination of IDH-Mutation Status IDH mutations were determined using immunohistochemistry, 14 , 15 DNA Extraction:Article Title: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas Article Snippet: .. In the nine cases in which DNA extraction was achieved (six cerebellar and three brainstem tumors), Mass Spectrometry:Article Title: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas Article Snippet: .. In the nine cases in which DNA extraction was achieved (six cerebellar and three brainstem tumors), Mutagenesis:Article Title: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas Article Snippet: .. In the nine cases in which DNA extraction was achieved (six cerebellar and three brainstem tumors), Fluorescence:Article Title: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas Article Snippet: .. In the nine cases in which DNA extraction was achieved (six cerebellar and three brainstem tumors), Polymerase Chain Reaction:Article Title: Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas Article Snippet: .. In the nine cases in which DNA extraction was achieved (six cerebellar and three brainstem tumors), |
